Cited by 1,513Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

Mullan, Mike, Crawford, Fiona, Axelman, Karin, Houlden, Henry, Lilius, Lena, Winblad, Bengt, Lannfelt, Lars·1992·Nature Genetics

DOI 10.1038/ng0892-345

Open this paper in CoChat — free account

Abstract

Mutations at codon 717 in exon 17 of the beta-amyloid precursor protein (APP) gene have previously been shown to segregate with early onset Alzheimer's disease in some families. We have identified a double mutation at codons 670 and 671 (APP 770 transcript) in exon 16 which co-segregates with the disease in two large (probably related) early-onset Alzheimer's disease families from Sweden. Two base pair transversions (G to T, A to C) from the normal sequence predict Lys to Asn and Met to Leu amino acid substitutions at codons 670 and 671 of the APP transcript. This mutation occurs at the amino terminal of beta-amyloid and may be pathogenic because it occurs at or close to the endosomal/lysosomal cleavage site of the molecule. Thus, pathogenic mutations in APP frame the beta-amyloid sequence.

Integrity signals

Registry

Crossref · 10.1038/ng0892-345

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Self-citation
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403
Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I. M., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,399
Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene
Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
Self-citation
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J. R., Farlow, M. R., Ghetti, B. F., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,142

Flagged first, then by citations

Show all 22 references

Research works printed but not linked: 2

Hardy, J. et al. Lancet 337, 1342–1343 (1991).
Weeks, D.E., Ott, J. & Lathrop, G M. Am. J. hum. Genet. 47(3), A204 (1990).

Sorted by citations

Items 501–600 of 1,002

Are the associations between Alzheimer's disease and polymorphisms in the apolipoprotein E and the apolipoprotein CII genes due to linkage disequilibrium?
Tsuda, T., Lopez, R., Rogaeva, E. A., Freedman, M., Rogaev, E. I., Drachman, D. A., Pollen, D. A., Haines, J. L., Liang, Y., McLachlan, D. R. C., et al. (1994) · Annals of Neurology · doi:10.1002/ana.410360118 · Cited by 54
N-truncated Abeta starting with position four: Early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody
Antonios, G., Saiepour, N., Bouter, Y., Richard, B. C., Paetau, A., Verkkoniemi-Ahola, A., Lannfelt, L., Ingelsson, M., Kovacs, G. G., Pillot, T., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-56 · Cited by 53
Self-citation
Genome-encoded cytoplasmic double-stranded RNAs, found in C9ORF72 ALS-FTD brain, propagate neuronal loss
Rodriguez, S., Şahin, A., Schrank, B. R., Lawati, H. J. A., Costantino, I. M., Benz, E. G., Fard, D., Albers, A. D., Cao, L., Gomez, A. C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz4699 · Cited by 58
Enhancement of Allele Discrimination by Introduction of Nucleotide Mismatches into siRNA in Allele-Specific Gene Silencing by RNAi
Ohnishi, Y., Tamura, Y., Yoshida, M., Tokunaga, K., & Hohjoh, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002248 · Cited by 53
Metabolism of the “Swedish” amyloid precursor protein variant in Madin-Darby canine kidney cells.
Lo, A., Haass, C., Wagner, S. L., Teplow, D. B., & Sisodia, S. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47376-0 · Cited by 53
Effects of statins on microglia
Lindberg, C., Crisby, M., Winblad, B. G., & Schultzberg, M. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20615 · Cited by 54
Self-citation
Alzheimer’s Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment
NAKAI, T., Yamada, K., & Mizoguchi, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115549 · Cited by 53
Subcellular Compartment and Molecular Subdomain of β-Amyloid Precursor Protein Relevant to the Aβ42-promoting Effects of Alzheimer Mutant Presenilin 2
Iwata, H., Tomita, T., Maruyama, K., & Iwatsubo, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007989200 · Cited by 52
Genetic aspects of Alzheimer's disease
Żekanowski, C., Religa, D., Graff, C., Filipek, S., & Kuźnicki, J. (2004) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2004-1488 · Cited by 52
The Arctic mutation interferes with processing of the amyloid precursor protein
Stenh, C., Nilsberth, C., ck, J. H., Engvall, B., Nšslund, J., & Lannfelt, L. (2002) · Neuroreport · doi:10.1097/00001756-200210280-00005 · Cited by 52
Self-citation
β-Secretase, APP and Aβ in Alzheimer’s Disease
Vassar, R. J. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_4 · Cited by 52
Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation
Kulic, L., McAfoose, J., Welt, T., Tackenberg, C., Späni, C. B., Wirth, F., Finder, V. H., Konietzko, U., Giese, M., Eckert, A., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.109 · Cited by 51
Translational Research on the Way to Effective Therapy for Alzheimer Disease
Rosenberg, R. N. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1186 · Cited by 51
Amyloid precursor protein, copper and Alzheimer's disease
Multhaup, G. (1997) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(97)86907-7 · Cited by 51
The Value of Transgenic Models for the Study of Neurodegenerative Diseases
Price, D. L., Wong, P. C., Markowska, A. L., Lee, M. K., THINAKAREN, G., Cleveland, D. W., Sisodia, S. S., & Borchelt, D. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06920.x · Cited by 52
Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment
Hagihara, H., Shoji, H., Hattori, S., Sala, G., Takamiya, Y., Tanaka, M., Ihara, M., Shibutani, M., Hatada, I., Hori, K., et al. (2023) · eLife · doi:10.7554/elife.89376 · Cited by 53
Sensitive and Continuous Screening of Inhibitors of β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) at Single SPR Chips
Yi, X., Hao, Y., Xia, N., Wang, J., QUINTERO, M., Li, D., & Zhou, F. (2013) · Analytical Chemistry · doi:10.1021/ac303624z · Cited by 50
A unique gene expression signature discriminates familial Alzheimer's disease mutation carriers from their wild-type siblings
Nagasaka, Y., Dillner, K., Ebise, H., Teramoto, R., Nakagawa, H., Lilius, L., Axelman, K., Forsell, C., Itô, A., Winblad, B. G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504178102 · Cited by 51
Self-citation
Amniotic Fluid Proteome Analysis from Down Syndrome Pregnancies for Biomarker Discovery
Cho, C.-K. J., Smith, C. R., & Diamandis, E. P. (2010) · Journal of Proteome Research · doi:10.1021/pr100088k · Cited by 50
Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?
Ziemka‐Nałęcz, M., Jaworska, J., Sypecka, J., & Zalewska, T. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly073 · Cited by 53
Expression of the amyloid protein precursor of Alzheimer's disease in the developing rat olfactory system
Clarris, H. J., Key, B., Beyreuther, K. T., Masters, C. L., & Small, D. H. (1995) · Developmental Brain Research · doi:10.1016/0165-3806(95)00083-p · Cited by 56
Cognitive phenotyping of amyloid precursor protein transgenic J20 mice
Karl, T., Bhatia, S., Cheng, D., Kim, W. S., & Garner, B. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.12.021 · Cited by 55
Recent Therapeutic Gene Editing Applications to Genetic Disorders
Deneault, É. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050255 · Cited by 54
UniProt genomic mapping for deciphering functional effects of missense variants
McGarvey, P. B., Nightingale, A., Luo, J., Huang, H., Martin, M. J., & Wu, C. H. (2019) · Human Mutation · doi:10.1002/humu.23738 · Cited by 50
NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats
Wilson, E. N., Carmo, S. D., Welikovitch, L. A., Hall, H., Aguilar, L. F., Foret, M. K., Iulita, M. F., Jia, D. T., Marks, A. R., Allard, S. T. M., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190862 · Cited by 50
Fluorine-18-Labeled Antibody Ligands for PET Imaging of Amyloid-β in Brain
Syvänen, S., Fang, X. T., Faresjö, R., Rokka, J., Lannfelt, L., Olberg, D. E., Eriksson, J., & Sehlin, D. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00652 · Cited by 52
Self-citation
Searching for new animal models of Alzheimer′s disease
Epis, R., Gardoni, F., Marcello, E. E., Genazzani, A. A., Canonico, P. L., & Luca, M. D. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.020 · Cited by 51
Review
Verbeek, M. M., Ruiter, D. J., & de Waal, R. M. W. (1997) · Biological Chemistry · doi:10.1515/bchm.1997.378.9.937 · Cited by 49
Identification of a metalloprotease from Alzheimer's disease brain able to degrade the .beta.-amyloid precursor protein and generate amyloidogenic fragments
Papastoitsis, G., Siman, R., Scott, R. W., & Abraham, C. R. (1994) · Biochemistry · doi:10.1021/bi00167a025 · Cited by 49
Amyloid β Peptide Formation in Cell-free Preparations
Desdouits, F., Buxbaum, J. D., Desdouits‐Magnen, J., Nairn, A. C., & Greengard, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24670 · Cited by 49
Genetic studies in Alzheimer's disease
Tang, Y., & Gershon, E. S. (2003) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2003.5.1/yptang · Cited by 52
Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges
Cynis, H., Frost, J. L., Crehan, H., & Lemere, C. A. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0115-2 · Cited by 49
Editing the Central Nervous System Through CRISPR/Cas9 Systems
Cota-Coronado, A., Díaz-Martínez, N. F., Padilla‐Camberos, E., & Diaz-Martinez, N. E. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00110 · Cited by 51
β-Amyloid Protein Precursor inMicrocebus murinus:Genotyping and Brain Localization
Silhol, S., Calenda, A., Jallageas, V., Mestre‐Francés, N., Bellis, M., & Bons, N. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0017 · Cited by 50
Familial conformational diseases and dementias
Crowther, D. C. (2002) · Human Mutation · doi:10.1002/humu.10100 · Cited by 48
Chasing genes in Alzheimer?s and Parkinson?s disease
Bertoli‐Avella, A. M., Oostra, B. A., & Heutink, P. (2004) · Human Genetics · doi:10.1007/s00439-004-1097-7 · Cited by 48
Glycosylphosphatidylinositol-anchored Proteins Play an Important Role in the Biogenesis of the Alzheimer's Amyloid β-Protein
Sambamurti, K., Sevlever, D., Koothan, T., Refolo, L. M., Pinnix, I., Gandhi, S., Onstead, L., Younkin, L. H., Prada, C.-M., Yager, D., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.26810 · Cited by 48
Alzheimer's disease amyloid precursor protein (ApPP): proteolytic processing, secretases and βA4 amyloid production
Evin, G. M., Beyreuther, K. T., & Masters, C. L. (1994) · Amyloid · doi:10.3109/13506129409146118 · Cited by 48
Genetics of dementia: Update and guidelines for the clinician
Cohn‐Hokke, P. E., Elting, M. W., Pijnenburg, Y. A. L., & Swieten, J. C. V. (2012) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32080 · Cited by 47
Rarity of the Alzheimer Disease–ProtectiveAPPA673T Variant in the United States
Wang, L.-S., Naj, A. C., Graham, R., Crane, P. K., Kunkle, B. W., Cruchaga, C., Murcia, J. D. G., Cannon‐Albright, L., Baldwin, C. T., Zetterberg, H., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2157 · Cited by 47
Wide Range of Disease Onset in a Family With Alzheimer Disease and a His163Tyr Mutation in the Presenilin-1 Gene
Axelman, K., Basun, H., & Lannfelt, L. (1998) · Archives of Neurology · doi:10.1001/archneur.55.5.698 · Cited by 47
Self-citation
Insights on the Use of Transgenic Mice Models in Alzheimer’s Disease Research
Pádua, M. S., Guil-Guerrero, J. L., Prates, J. A. M., & Lopes, P. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052805 · Cited by 46
The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model
Puri, V., Wang, X., Vardigan, J. D., Kuduk, S. D., & Uslaner, J. M. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.03.029 · Cited by 46
High intracellular concentrations of amyloid‐beta block nuclear translocation of phosphorylated CREB
Arvanitis, D. N., Ducatenzeiler, A., Ou, J.-N., Grodstein, E. I., Andrews, S. D., Tendulkar, S. R., Ribeiro‐da‐Silva, A., Szyf, M., & Cuello, A. C. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04704.x · Cited by 46
Alzheimer’s Disease: From Genetic Variants to the Distinct Pathological Mechanisms
Sun, Q., Xie, N., Tang, B., Li, R., & Shen, Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00319 · Cited by 46
Cadmium in blood in Alzheimer's disease and non-demented subjects: results from a population-based study
Basun, H., Lind, B., Nordberg, M., Nordstr�m, M., Björkstén, K. S., & Winblad, B. G. (1994) · BioMetals · doi:10.1007/bf00140482 · Cited by 46
Self-citation
Alzheimer's Disease Families with Amyloid Precursor Protein Mutationsa
Rossor, M. N., Newman, S., Frackowiak, R. S. J., Lantos, P. L., & Kennedy, A. M. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23052.x · Cited by 46
A transgenic rat expressing human APP with the Swedish Alzheimer’s disease mutation
Folkesson, R., Małkiewicz, K., Kloskowska, E., Nilsson, T., Popova, E., Bogdanović, N., Ganten, U., Ganten, D., Bäder, M., Winblad, B. G., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.195 · Cited by 49
Self-citation
Abnormalities in Alzheimer’s Disease Fibroblasts Bearing the APP670/671 Mutation
Gibson, G. E., Vestling, M., Zhang, H., Szolosi, S., Alkon, D. L., Lannfelt, L., Gandy, S., & Cowburn, R. F. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00149-8 · Cited by 46
Self-citation
Calretinin-immunoreactive neurons are resistant to β-amyloid toxicity in vitro
Pike, C. J., & Cotman, C. W. (1995) · Brain Research · doi:10.1016/0006-8993(94)01354-k · Cited by 46
Processing of Alzheimer Aβ-Amyloid Precursor Protein: Cell Biology, Regulation, and Role in Alzheimer Disease
Gandy, S., & Greengard, P. (1994) · International review of neurobiology · doi:10.1016/s0074-7742(08)60302-5 · Cited by 46
β-amyloid: The known unknowns
Ayton, S., & Bush, A. I. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101212 · Cited by 45
Assessing Drug Administration Techniques in Zebrafish Models of Neurological Disease
Chaoul, V., Dib, E., Bedran, J., Khoury, C., Shmoury, O., Harb, F., & Soueid, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914898 · Cited by 47
Progressive neuropathology and cognitive decline in a single Arctic APP transgenic mouse model
Rönnbäck, A., Zhu, S., Dillner, K., Aoki, M., Lilius, L., Näslund, J., Winblad, B. G., & Graff, C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.021 · Cited by 47
Self-citation
Expression of the Alzheimer’s Disease Mutations AβPP695sw and PSEN1M146I in Double-Transgenic Göttingen Minipigs
Jakobsen, J. E., Johansen, M., Schmidt, M. H., Liu, Y., Li, R., Callesen, H., Melnikova, M., Habekost, M., Matrone, C., Bouter, Y., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160408 · Cited by 45
AβPP/PS1 Transgenic Mice Show Sex Differences in the Cerebellum Associated with Aging
Ordóñez‐Gutiérrez, L., Fernandez-Perez, I., Herrera, J. L., Anton, M., Benito‐Cuesta, I., & Wandosell, F. G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160572 · Cited by 47
High fat diet treatment impairs hippocampal long-term potentiation without alterations of the core neuropathological features of Alzheimer disease
Salas, I. H., Weerasekera, A., Ahmed, T., Callaerts‐Vegh, Z., Himmelreich, U., D’Hooge, R., Balschun, D., Saido, T. C., Strooper, B. D., & Dotti, C. G. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.02.001 · Cited by 46
Processing of Mutant β-Amyloid Precursor Protein and the Clinicopathological Features of Familial Alzheimer’s Disease
Bi, C., Bi, S., & Li, B. (2018) · Aging and Disease · doi:10.14336/ad.2018.0425 · Cited by 46
Genetic Dissection of Alzheimer’s Disease Using Drosophila Models
Jeon, Y., Lee, J., Choi, B., Won, S.-Y., & Cho, K. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030884 · Cited by 46
Age of onset in familial early onset Alzheimer's disease correlates with genetic aetiology
MULLAN, M. J., Houlden, H., Crawford, F., Kennedy, A. M., Rogues, P. K., & Rossor, M. N. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320480303 · Cited by 46
Self-citation
APP transgenesis: Approaches toward the development of animal models for Alzheimer disease neuropathology
Greenberg, B., Savage, M. J., Howland, D., Ali, S. M., Siedlak, S. L., Perry, G. L., Siman, R., & Scott, R. W. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00001-2 · Cited by 45
Recent Advances in the Genetics of Alzheimer's Disease
Levy‐Lahad, E., Tsuang, D. W., & Bird, T. D. (1998) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879801100202 · Cited by 46
Amyloid precursor protein drives down-regulation of mitochondrial oxidative phosphorylation independent of amyloid beta
Lopez Sanchez, M. I. G., Waugh, H. S., Tsatsanis, A., Wong, B. X., Crowston, J. G., Duce, J. A., & Trounce, I. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-10233-0 · Cited by 45
Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer’s Disease
Petralla, S., Panayotova, M., Franchina, E., Fricker, G., & Puris, E. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070948 · Cited by 46
The dopaminergic system promotes neprilysin-mediated degradation of amyloid-β in the brain
Watamura, N., Kakiya, N., Fujioka, R., Kamano, N., Takahashi, M., Nilsson, P., Saito, T., Iwata, N., Fujisawa, S., & Saido, T. C. (2024) · Science Signaling · doi:10.1126/scisignal.adk1822 · Cited by 44
Amyloid-β metabolism in Niemann-Pick C disease models and patients
Mattsson, N., Olsson, M., Gustavsson, M. K., Košiček, M., Malnar, M., Månsson, J., Blomqvist, M., Gobom, J., Andréasson, U., Brinkmalm, G., et al. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9332-8 · Cited by 45
High Fat Diet Enhances β-Site Cleavage of Amyloid Precursor Protein (APP) via Promoting β-Site APP Cleaving Enzyme 1/Adaptor Protein 2/Clathrin Complex Formation
Maesako, M., Uemura, M. T., Tashiro, Y., Sasaki, K., Watanabe, K., Noda, Y., Ueda, K., Asada‐Utsugi, M., Kubota, M., Okawa, K., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131199 · Cited by 44
Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer’s disease and transgenic mouse models
Reinert, J., Richard, B. C., Klafki, H., Friedrich, B., Bayer, T. A., Wiltfang, J., Kovács, G. G., Ingelsson, M., Lannfelt, L., Paetau, A. E., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0294-7 · Cited by 44
Self-citation
Emerging roles of N- and C-terminally truncated Aβ species in Alzheimer’s disease
Wirths, O., & Zampar, S. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1702972 · Cited by 44
11. Molecular genetics of Alzheimer's disease
Hardy, J., Owen, M. J., Goate, A., James, L., Haynes, A. R., Williamson, R., Roques, P. K., Rossor, M. N., & Mullan, M. J. (1989) · Biochemical Society Transactions · doi:10.1007/978-1-4613-0513-2_3 · Cited by 44
Self-citation
Potential Treatment Opportunities for Alzheimer's Disease Through Inhibition of Secretases and Aβ Immunization
Schenk, D., Games, D., & Seubert, P. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:259 · Cited by 44
Microtubule-associated protein tau in human fibroblasts with the Swedish Alzheimer mutation
Ingelson, M., Vanmechelen, E., & Lannfelt, L. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13218-3 · Cited by 44
Self-citation
Genetic Epidemiology of Alzheimer Disease
Slooter, A. J. C., & van Duijn, C. M. (1997) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017933 · Cited by 44
Increased Aβ 42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene
Ishii, K., Ii, K., Hasegawa, T., Shoji, S., Doi, A., & Mori, H. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00347-9 · Cited by 44
Diverse roles of Synaptotagmin-7 in regulating vesicle fusion
Huson, V., & Regehr, W. G. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.02.006 · Cited by 43
The effects of different familial Alzheimer’s disease mutations on APP processing in vivo
Þórðardóttir, S., Ståhlbom, A. K., Almkvist, O., Thonberg, H., Eriksdotter, M., Zetterberg, H., Blennow, K., & Graff, C. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0234-1 · Cited by 47
State of Play in Alzheimer’s Disease Genetics
Zhu, J.-B., Tan, C., Tan, L., & Yu, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170062 · Cited by 44
Alix and Syntenin-1 direct amyloid precursor protein trafficking into extracellular vesicles
Cone, A. S., Hurwitz, S. N., Lee, G. S., Yuan, X., Zhou, Y., Li, Y., & Meckes, D. G. (2020) · BMC Molecular and Cell Biology · doi:10.1186/s12860-020-00302-0 · Cited by 44
Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576
Tehranian, R., Hasanvan, H., Iverfeldt, K., Post, C., & Schultzberg, M. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01592-0 · Cited by 43
An Update on the Amyloid Hypothesis
Eckman, C. B., & Eckman, E. A. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.007 · Cited by 43
Rank-Order of Potencies for Inhibition of the Secretion of Aβ40 and Aβ42 Suggests That Both Are Generated by a Single γ-Secretase
Durkin, J. T., Murthy, S., Husten, E. J., Trusko, S. P., Savage, M. J., Rotella, D. P., Greenberg, B., & Siman, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20499 · Cited by 43
Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease
Brindle, N. P. J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.5.933 · Cited by 43
GPR3 Stimulates Aβ Production via Interactions with APP and β-Arrestin2
Nelson, C. D., & Sheng, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074680 · Cited by 42
The past, present, and future of disease-modifying therapies for Alzheimer’s disease
Suzuki, K., Iwata, A., & Iwatsubo, T. (2017) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.93.048 · Cited by 42
Blood-brain barrier integrity in a mouse model of Alzheimer's disease with or without acute 3D6 immunotherapy
Gustafsson, S. S., Gustavsson, T., Roshanbin, S., Hultqvist, G., Hammarlund‐Udenaes, M., Sehlin, D., & Syvänen, S. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.001 · Cited by 44
Sorting Out the Role of the Sortilin-Related Receptor 1 in Alzheimer’s Disease
Barthelson, K., Newman, M., & Lardelli, M. T. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200177 · Cited by 43
Mechanistic and therapeutic role of Drp1 in the pathogenesis of Alzheimer's disease
Bera, A., Lavanya, G., Reshmi, R., Dev, K., & Kumar, R. K. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15611 · Cited by 43
Amyloid-β Oligomers: Multiple Moving Targets
Shea, D. W., & Daggett, V. (2022) · Biophysica · doi:10.3390/biophysica2020010 · Cited by 43
Enhanced activity of Alzheimer disease-associated variant of protein kinase Cα drives cognitive decline in a mouse model
Lordén, G., Wozniak, J. M., Doré, K., Dozier, L. E., Cates‐Gatto, C., Patrick, G. N., Gonzalez, D. J., Roberts, A. J., Tanzi, R. E., & Newton, A. C. (2022) · Nature Communications · doi:10.1038/s41467-022-34679-7 · Cited by 45
Immunocytochemical localization of amyloid precursor protein in rat brain
Ouimet, C. C., Baerwald, K. D., Gandy, S., & Greengard, P. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903480207 · Cited by 41
Amyloid precursor protein is enriched in radial glia: Implications for neuronal development
Trapp, B. D., & Hauer, P. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370413 · Cited by 43
Cerebrospinal fluid brain‐derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt–Jakob disease
Green, A. J. E. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.t01-2-00427.x · Cited by 41
The βA4 Amyloid Precursor Protein Gene and Alzheimer's Disease
Hendriks, L., & Broeckhoven, C. V. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0006n.x · Cited by 41
A population-based study of familial Alzheimer disease: linkage to chromosomes 14, 19, and 21.
van Duijn, C. M., Hendriks, L., Farrer, L. A., Backhovens, H., Cruts, M., Wehnert, A., Albert Hofman, D., & Broeckhoven, C. V. (1994) · PubMed · Cited by 41
Alzheimer risk-increasing TREM2 variant causes aberrant cortical synapse density and promotes network hyperexcitability in mouse models
Das, M. M., Mao, W., Voskobiynyk, Y., Necula, D., Lew, I., Petersen, C., Zahn, A., Yu, G.-Q., Yu, X., Smith, N., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106263 · Cited by 41
Human Alzheimer’s disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology
Rothman, S. M., Tanis, K. Q., Gandhi, P., Malkov, V. A., Marcus, J., Pearson, M. S., Stevens, R. C., Gilliland, J., Ware, C. M., Mahadomrongkul, V., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1265-7 · Cited by 41
Exome-wide age-of-onset analysis reveals exonic variants in ERN1 and SPPL2C associated with Alzheimer’s disease
He, L., Loika, Y., Park, Y., Bennett, D. A., Kellis, M., Kulminski, A. M., & Initiative, A. D. N. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01263-4 · Cited by 41
Pharmacogenomics for the treatment of dementia
Cacabelos, R. (2002) · Annals of Medicine · doi:10.1080/078538902320772115 · Cited by 40
Mutant and native human β-amyloid precursor proteins in transgenic mouse brain
Howland, D. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00078-s · Cited by 40
Amyloid β-peptide in cerebrospinal fluid in individuals with the Swedish Alzheimer amyloid precursor protein mutation
Lannfelt, L., Basun, H., Vigo-Pelfrey, C., Wahlund, L.-O., Winblad, B., Lieberburg, I., & Schenk, D. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12059-d · Cited by 39
Self-citation

Authors: Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L.
Affiliations: University of South Florida (US)
Karolinska Institutet (SE)
St Mary's Hospital (GB)
ORCID: Crawford, Fiona
Houlden, Henry
Winblad, Bengt
Lannfelt, Lars
Venue: Nature Genetics
Publisher: Springer Science and Business Media LLC
Published: 1992-08
Volume: 1
Issue: 5
Pages: 345-347
ISSN: 1061-4036 (ISSN-L)
1546-1718
DOI: 10.1038/ng0892-345
OpenAlex: W2030641075
Cited by: 1,513
References: 22
Citations by year: 2026: 24 · 2025: 30 · 2024: 50 · 2023: 47 · 2022: 49 · 2021: 46 · 2020: 52 · 2019: 56 · 2018: 48 · 2017: 48 · 2016: 47 · 2015: 31 · 2014: 62 · 2013: 31 · 2012: 32
FWCI: 49.77
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Genetics (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: Alzheimer's disease, APP gene, amyloid-beta, early-onset familial Alzheimer's disease, Swedish families
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Base Sequence, Brain, Codon, Exons, Female, Humans, Genetic Linkage, Male, Middle Aged, Molecular Sequence Data, Oligodeoxyribonucleotides, Pedigree, Transcription, Genetic, Genetic Variation, Amyloid beta-Protein Precursor, Point Mutation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks